4.7 Article

Poor Adherence to Self-Applied Topical Drug Treatment Is a Common Source of Low Lesion Clearance in Patients with Actinic Keratosis-A Cross-Sectional Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Actinic Keratoses (AK): An Exploratory Questionnaire-Based Study of Patients' Illness Perceptions

Dimitrios Sgouros et al.

Summary: This study aimed to investigate the illness and treatment perceptions of AK patients, as well as their correlation to demographics and AK/skin cancer history, and the influence of these perspectives on treatment and sunscreen use. The awareness of AK among patients was found to be poor, with education level playing a role in disease awareness and treatment plan perception. Female and younger patients had a higher increase in sunscreen protection after AK diagnosis. Patients' concerns regarding treatment were mainly related to the duration and effectivity. Dermatologists' statements highlighting that AK are precancerous lesions influenced patients' willingness for treatment.

CURRENT ONCOLOGY (2022)

Article Medicine, General & Internal

Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis

Andrew Blauvelt et al.

Summary: Tirbanibulin, a tubulin polymerization and Src kinase inhibitor, was more effective than placebo ointment in clearing actinic keratoses on the face and scalp at 2 months. However, recurrence of lesions occurred in 47% of patients at 1 year, with adverse events related to local irritation.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Pharmacology & Pharmacy

Safety of topical interventions for the treatment of actinic keratosis

Elias A. T. Koch et al.

Summary: In summary, actinic keratosis requires early treatment and there are various effective approaches available, although local adverse events may occur during the treatment process, so it is important to carefully choose the appropriate treatment medication. In the future, safety concerns will focus on long-term adverse drug events and the incidence of non-melanoma skin cancers associated with treatment.

EXPERT OPINION ON DRUG SAFETY (2021)

Editorial Material Dermatology

The NVKH launches the Skin Cancer Information Portal

Friedegund Meier et al.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2021)

Review Medicine, General & Internal

A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance Trials

Theresa Steeb et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Geriatrics & Gerontology

The High Prevalence of Skin Diseases in Adults Aged 70 and Older

Suvi-Paivikki Sinikumpu et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2020)

Article Medicine, General & Internal

Randomized Trial of Four Treatment Approaches for Actinic Keratosis

Maud H. E. Jansen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Chemistry, Medicinal

Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361)

Michael P. Smolinski et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Editorial Material Dermatology

Adherence to topical treatments for actinic keratosis

L. A. Cardwell et al.

BRITISH JOURNAL OF DERMATOLOGY (2016)

Review Dermatology

Adherence to topical therapies in actinic keratosis: A literature review

Peter Foley et al.

JOURNAL OF DERMATOLOGICAL TREATMENT (2016)

Review Medicine, General & Internal

Interventions to Increase Treatment Adherence in Pediatric Atopic Dermatitis: A Systematic Review

Alexandria M. Bass et al.

JOURNAL OF CLINICAL MEDICINE (2015)

Review Chemistry, Medicinal

Topical imiquimod: mechanism of action and clinical applications

D Vidal

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)

Article Biochemistry & Molecular Biology

Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development

Y. M. Sung et al.

ONCOGENE (2006)

Article Dermatology

Imiquimod: modes of action

DN Sauder

BRITISH JOURNAL OF DERMATOLOGY (2003)